ALEXION PHARMACEUTICALS $102.67

up +2.64


21/5/2013 04:21 PM  |  NASDAQ : ALXN  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 22% - ALXN has underperformed the S&P 500 by 7%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. UPDATE: Stifel Nicolaus Cuts PT to $118 on Alexion ...

    Benzinga

  2. Regeneron, Alexion Top; Fall

    Investors Business Daily

  3. Earnings Scheduled For February 14, 2013

    Benzinga

  4. Regeneron, Alexion Big-Cap Biotechs Sales Seen Rising

    Investors Business Daily

  5. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga

  6. Alexion Recommends Rejection of $90.50/Share Mini-Tender Offer by ...

    Benzinga

  7. Alexion Pharmaceuticals, Inc. (ALXN) EVP & CFO Vikas Sinha sells ...

    GuruFocus

  8. Alexion Pharmaceuticals, Inc. (ALXN) CEO Leonard Bell sells 11,880 ...

    GuruFocus

  9. Alexion Pharmaceuticals, Inc. (ALXN) EVP & CFO Vikas Sinha sells ...

    GuruFocus

  10. Alexion Pharmaceuticals, Inc. (ALXN) CEO Leonard Bell sells 5,242 ...

    GuruFocus

  11. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga

  12. Alexion Says UK Unit Informed AGNSS Recommendation for Soliris ...

    Benzinga

  13. Alexion Pharmaceuticals, Inc. (ALXN) CEO Leonard Bell sells 35,000 ...

    GuruFocus

  14. Alexion Pharmaceuticals, Inc. (ALXN) CEO Leonard Bell sells 27,197 ...

    GuruFocus

  15. Alexion Pharmaceuticals, Inc. (ALXN) CEO Leonard Bell sells 7,803 ...

    GuruFocus

  16. Stocks Burst Higher In Solid Volume Amid Sighs Of Relief

    Investors Business Daily

  17. 2013 Opens To Two-Fisted Rally; Hewlett Packard Rebounds 5%

    Investors Business Daily

  18. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga

  19. Alexion Pharmaceuticals, Inc. (ALXN) CEO Leonard Bell sells 35,000 ...

    GuruFocus

  20. Option Trends: Alexion Pharmaceuticals, Starbucks, and VMware

    By SchaeffersResearch

  21. When Follow-Through Occurs, Watch Strong Industries

    Investors Business Daily

  22. Benzinga's Top Initiations

    Benzinga

  23. Alexion Pharmaceuticals, Inc. (ALXN) CEO Leonard Bell sells 48,515 ...

    GuruFocus

  24. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    Investors Business Daily

  25. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga

  26. Alexion Announces $400 Million Share Repurchase Program

    Benzinga

  27. Reel In Price Target, Sell Rules In Rough Market

    Investors Business Daily

  28. BioMarin Stock Soars On Positive Drug Data

    Investors Business Daily

  29. Alexion Pharmaceuticals, Inc. (ALXN) CEO Leonard Bell sells 7,982 ...

    GuruFocus

  30. The 8% Sell Rule Keeps Losses Small, Shields Capital

    Investors Business Daily

  31. Don't Stay Married to the Old Leaders; Target New Leadership

    Benzinga

  32. IBD Chairman William O'Neil: Supercycle Bull May Arrive

    Investors Business Daily

  33. Alexion Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus

  34. More Leaders Get Hit, But Some Are Forming Buy Setups

    Investors Business Daily

  35. Stock Averages Advance Modestly In Mixed Turnover

    Investors Business Daily

  36. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga

  37. Stocks Climb In Mixed Trade; Three D Systems Gaps Up

    Investors Business Daily

  38. Alexion EPS Tops, Shares Fall

    Investors Business Daily

  39. Alexion Earnings Beat Street, But Stock Still Sliding

    Investors Business Daily

  40. Stocks Waver To Lower Close; Akamai Jumps After Hours

    Investors Business Daily

  41. Stocks Turn Mixed At Midday; Facebook Up On Strong Profit

    Investors Business Daily

  42. IBD 50: Alexion Earnings Beat Estimates; Stock Up

    Investors Business Daily

  43. Boeing, Panera Bread Jump As Stock Futures Strengthen

    Investors Business Daily

  44. Alexion, Texas Capital Among IBD 50 With Earnings Due

    Investors Business Daily

  45. Top 5 Big Cap Stocks Led By Michael Kors, Alexion

    Investors Business Daily

  46. Stocks Worsen Near Midday But Nationstar Gains

    Investors Business Daily

  47. Alexion Earnings Expected To Grow, But Stock Slides

    Investors Business Daily

  48. Big Caps Taking Heat; Alexion Breakout Crumbling

    Investors Business Daily

  49. Stocks Rise Thanks To Last-Hour Push

    Investors Business Daily

  50. Apple Earnings Lead 5 IBD 50 Tech Reports This Week

    Investors Business Daily

  51. Gilead, Amgen Earnings To Launch Busy Biotech Week

    Investors Business Daily

  52. Stocks Mixed As Comeback Fades; Alexion Extends Losses

    Investors Business Daily

  53. Stocks Mixed In Early Trade; Apple, Priceline.com Rebound

    Investors Business Daily

  54. Apple Earnings Lead 5 IBD 50 Tech Reports This Week

    Investors Business Daily

  55. Stocks Tumble On Disappointing Earnings Reports

    Investors Business Daily

  56. Stocks Hit Fresh Intraday Lows; Google Reverses Lower

    Investors Business Daily

  57. Madison Square Garden, Stratasys Catch Their Breath

    Investors Business Daily

  58. Medical, Cable, Credit Card Stocks Top IBD Big Cap 20

    Investors Business Daily

  59. Seven Leading Stocks With Rising Earnings Estimates

    Investors Business Daily

  60. Many Stocks Dip In Weak Trade Amid Market Correction

    Investors Business Daily

  61. Medical Leaders Hang Tough; Alexion Tests Buy Point

    Investors Business Daily

  62. UPDATE: Bank of America Raises PO to $130 on Alexion ...

    Benzinga

  63. Alexion, Amgen Among Top 5 Big-Cap Medical Leaders

    Investors Business Daily

  64. Alexion Says Clinical, Statistical Improvement in 2nd Endpoints of ...

    Benzinga

  65. Alexion, Other Medical Stocks Fill Up IBD Big Cap 20

    Investors Business Daily

  66. SolarWinds, Mellanox, Alexion Lead IBD 50's Five Best

    Investors Business Daily

  67. Tractor Supply, Others Break Out As Market Rallies

    Investors Business Daily

  68. Alexion Pharmaceuticals Inc. (ALXN) CEO Leonard Bell sells 18,070 ...

    GuruFocus

  69. Sarepta Stock Jumps On Muscular Dystrophy Drug Trial

    Investors Business Daily

  70. Top Funds Favor Health Care, Retail In Recent Buys ALXN CTRX

    Investors Business Daily

  71. Several Big Cap 20 Stocks Hit New Highs, In Buy Area

    Investors Business Daily

  72. Alexion Pharmaceuticals Inc. (ALXN) CEO Leonard Bell sells 143,100 ...

    GuruFocus

  73. Many IBD 50 Stocks Find Support After Pulling Back

    Investors Business Daily

  74. Questcor Rises On Dividend, Aetna News Ups Dendreon

    Investors Business Daily

  75. Alexion, Apple, Google Among Big Cap Stock Leaders

    Investors Business Daily

  76. Stocks Open Higher on Consumer Confidence, Home Price Data

    At Market Intelligence Center

  77. Stocks Hold Near Highs; Michael Kors Cuts Losses

    Investors Business Daily

  78. Biogen, Cubist and Alexion Not The Only Biomed Leaders

    Investors Business Daily

  79. Alexion, Visa, Others Holding In Possible Buy Ranges

    Investors Business Daily

  80. Alexion, Blucora In Buy Area After Flat-Base Breakouts

    Investors Business Daily

  81. Gold Miners, Jewelers Jump, But Offer No Leading Stocks

    Investors Business Daily

  82. Luxury Brand Kors, Biotechs Dominate Daily Screen

    Investors Business Daily

  83. IBD 50: Questcor Shares Up On Acthar August Sales

    Investors Business Daily

  84. Top Funds Keep Fire Burning Under Alexion

    Investors Business Daily

  85. Weekly Top Insider Sells: GOOG, KSS, ALXN, and QCOM

    GuruFocus

  86. Stocks Ease Near Midday; Fresh Market Reverses, But Francesca's Up

    Investors Business Daily

  87. Kors, Apple, Big Names On Big Cap Screen Of the Day

    Investors Business Daily

  88. Alexion Developing New Drugs To Keep Profits Humming

    Investors Business Daily

  89. Look For Big Caps No. 1 In Their Industry Groups

    Investors Business Daily

  90. Short Interest in Biotech Firms on the Rise

    Benzinga

  91. Apple, 4 Other Techs Remain On IBD 50 One-Year Later

    Investors Business Daily

  92. Let's Set Aside Facebook Comparisons and Look at LinkedIn as a ...

    YCharts

  93. Regeneron Trying To Break Out, Near New High

    Investors Business Daily

  94. The New Pharmaceutical Blockbusters: Orphan Drugs

    YCharts

  95. Big Cap 20: More Stocks Flirting With Entries

    Investors Business Daily

  96. More Top Stocks Stage Breakouts

    Investors Business Daily

  97. Apple, Google, Western Digital Among Big Cap Leaders

    Investors Business Daily

  98. Health Care Stocks Continue To Lead Market

    Investors Business Daily

  99. Biotechs: Basing, With Possible Leaders On Deck

    Investors Business Daily

  100. Amgen Spearheads Strong Medical Showing In Big Cap 20

    Investors Business Daily
People viewing ALXN also viewed: , , , , , ,
Marketplace
Trading Center